Tuberc Respir Dis.  2006 Sep;61(3):207-213. 10.4046/trd.2006.61.3.207.

Lung Cancer Screening

• Kim JO

• KMID: 1970258
• DOI: http://doi.org/10.4046/trd.2006.61.3.207

Abstract

No abstract available.

MeSH Terms

Lung Neoplasms*
Lung*
Mass Screening*

Figure

• 

  Figure 1 Mortality in randomized controlled trials* of lung cancer screening with chest radiography with or without sputum cytology adapted from Hunphrey et al1

• 

  Figure 2 20. Noncalcified pulmonaty nodule detected by CT was 259 persons(46%), and lung cancer prevalence was 2.3%(14/561). Adapted from McWillams et al20.

Reference

1. Humphrey LL, Teutsch S, Johnson MS. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2004. 140:740–753.

2. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002. 20:911–920.

3. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998. 351:1242–1245.

4. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral ccomputed tomography scanner. Br J Cancer. 2001. 84:25–32.

5. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999. 354:99–105.

6. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001. 922:153–159.

7. Swensen S, Jett JR, Slon JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002. 165:508–513.

8. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003. 226:756–761.

9. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of baseline examinations in 817 asymptomatic smokers. Radiology. 2002. 222:773–781.

10. Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol. 2004. 14:691–702.

11. Pastorino U, Bellomi M, Landoni C, de Fiori E, Arnaldi P, Picchio M, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet. 2003. 362:593–597.

12. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H, et al. Lung cancer screening using low-dose spiral CT. Chest. 2002. 122:15–20.

13. Chong SM, Lee KS, Chung MJ, Kjm TS, Kim HJ, Kwon OJ, et al. Lung cancer screening with low-dose helical CT in Korea: experience at the Samsung Medical Center. J Korean Med Sci. 2005. 20:402–408.

14. Diederich S, Wormanns D. Impact of low-dose CT on lung cancer screening. Lung Cancer. 2004. 45:S13–S19.

15. McWilliams A, Lam S. Lung cancer screening. Curr Opin Pulm Med. 2005. 11:272–277.

16. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006. 61:54–56.

17. Lam S, MacAulay C, le Riche JC, Palcic B. Detection and localization of early lung cancerr by fluorescence bronchoscopy. Cancer. 2000. 89:2468–2473.

18. Häuβinger K, Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with light bronchoscopy compared with white light bronchosocpy alone for the detection of precancerous lesions: a European randomized controlled multicentre trial. Thorax. 2005. 60:496–503.

19. Kennedy TC, Miller Y, Prindiville S. Screening for lung cancer revisited and the role of sptum cytology and fluorescence bronchscopy in a high risk group. Chest. 2000. 117:72S–79S.

20. McWilliams A, Mayo J, MacDonald S, le Riche JC, Palcic B, Szabo E, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med. 2003. 168:1167–1173.

21. Banerjee AK, Rabbitts PH, George J. Flourescence bronchoscopy: clinical dilemmas and reseach opportunities. Thorax. 2003. 58:266–271.

22. Sing A, Freudenberg N, Korsik C, Wertzel N, Klosa B, Hasee J. Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lugn cnarcinomas. Acta Cytol. 1997. 41:399–408.

23. Kennedy TC, Hirsch FR. Using molecular markers in sputum for the early detection of lung cancer: a review. Lung Cancer. 2004. 45:S21–S27.

24. Thunnissen FB. Sptum examination for early detection of lung cancer. J Clin Pathol. 2003. 56:805–810.

25. Huber RM, Statakis DF. Molecular oncology: perspectives in lung cancer. Lung Cancer. 2004. 45:S209–S213.

26. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Cleeson K, Greenberg J, et al. Detection of lung cancer with volatile markers in the breath. Chest. 2003. 123:2115–2123.

27. Jheon S, Hyun DS, Lee SC, Yoon GS, Jeon CH, Park JW, et al. Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers. Lung Cancer. 2004. 43:29–37.

28. Deppermann KM. Lung cancer screening: where are we in 2004. Lung Cancer. 2004. 45:S39–S42.

29. Ashton RW, Jett JR. Screening for non-small cell lung cancer. Semin Oncol. 2005. 32:253–258.

30. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006. 61:54–56.

31. Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk Noordegraaf A, Risse EJ, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005. 11:537–543.